Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

K. Takahashi, E. Jabbour, X. Wang, R. Luthra, C. Bueso-Ramos, K. Patel, S. Pierce, H. Yang, Y. Wei, N. Daver, S. Faderl, F. Ravandi, Z. Estrov, J. Cortes, H. Kantarjian, G. Garcia-Manero

Research output: Contribution to journalLetter

26 Scopus citations
Original languageEnglish (US)
Pages (from-to)2081-2083
Number of pages3
JournalLeukemia
Volume27
Issue number10
DOIs
StatePublished - Oct 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Takahashi, K., Jabbour, E., Wang, X., Luthra, R., Bueso-Ramos, C., Patel, K., Pierce, S., Yang, H., Wei, Y., Daver, N., Faderl, S., Ravandi, F., Estrov, Z., Cortes, J., Kantarjian, H., & Garcia-Manero, G. (2013). Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. Leukemia, 27(10), 2081-2083. https://doi.org/10.1038/leu.2013.165